Search

Your search keyword '"NERI, IRIA"' showing total 23 results
Start Over Author "NERI, IRIA" Journal italian journal of dermatology and venereology
23 results on '"NERI, IRIA"'

3. COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study

Author

ROMITA, Paolo, primary, MARONESE, Carlo A., additional, DE MARCO, Aurora, additional, BALESTRI, Riccardo, additional, BELLONI FORTINA, Anna, additional, BRAZZELLI, Valeria, additional, COLONNA, Cristiana, additional, DI LERNIA, Vito, additional, EL HACHEM, May, additional, FABBROCINI, Gabriella, additional, FRASIN, Lucretia A., additional, GUARNERI, Claudio, additional, GUERRIERO, Cristina, additional, GUIDA, Stefania, additional, LOCATELLI, Andrea, additional, NERI, Iria, additional, OCCELLA, Corrado, additional, OFFIDANI, Annamaria, additional, ORANGES, Teresa, additional, PELLACANI, Giovanni, additional, STINCO, Giuseppe, additional, STINGENI, Luca, additional, BARBAGALLO, Tania, additional, CAMPANATI, Anna, additional, CANNAVÒ, Serafinella P., additional, CAROPPO, Francesca, additional, CAVALLI, Riccardo, additional, COSTANTINI, Alessio, additional, CUCCHIA, Rosa, additional, DIOCIAIUTI, Andrea, additional, FILIPPESCHI, Cesare, additional, FRANCOMANO, Mariangela, additional, GIANCRISTOFORO, Simona, additional, GIUFFRIDA, Roberta, additional, MARTINA, Emanuela, additional, MONZANI, Nicola A., additional, NAPPA, Paola, additional, PASTORINO, Carlotta, additional, PATRIZI, Annalisa, additional, PECCERILLO, Francesca, additional, PERIS, Ketty, additional, RECALCATI, Sebastiano, additional, RIZZOLI, Laura, additional, SIMONETTI, Oriana, additional, VASTARELLA, Maria, additional, VIRDI, Annalucia, additional, MARZANO, Angelo V., additional, and BONAMONTE, Domenico, additional

Published
2023
Full Text
View/download PDF

10. A retrospective study on clinical subtypes and management of morphea in 10 Italian Dermatological Units

Author

VIRDI, Annalucia, primary, PATRIZI, Annalisa, additional, CAMBIAGHI, Stefano, additional, DIOCIAIUTI, Andrea, additional, EL HACHEM, May, additional, SCHENA, Donatella, additional, BASSI, Andrea, additional, BONAMONTE, Domenico, additional, BRAZZELLI, Valeria, additional, BELLONI FORTINA, Anna, additional, PEPE, Patrizia, additional, DI LERNIA, Vito, additional, and NERI, Iria, additional

Published
2021
Full Text
View/download PDF

19. Treatment patterns with systemic antipsoriatic agents in childhood psoriasis: an Italian database analysis

Author

Di Lernia, Vito, primary, Neri, Iria, additional, Calzavara Pinton, Piergiacomo, additional, Di Nuzzo, Sergio, additional, Stingeni, Luca, additional, Guarneri, Claudio, additional, Belloni Fortina, Anna, additional, Bonamonte, Domenico, additional, Cambiaghi, Stefano, additional, Lasagni, Claudia, additional, Panzone, Michele, additional, Corazza, Monica, additional, Offidani, Annamaria, additional, and Gisondi, Paolo, additional

Published
2017
Full Text
View/download PDF

21. Atopic dermatitis in schoolchildren and adolescents: a critical review of Italian epidemiological data and systemic treatments.

Author

El Hachem M, Naldi L, Neri I, Pedone MP, Fanelli F, and Galeone C

Subjects
Administration, Topical, Adolescent, Child, Child, Preschool, Humans, Incidence, Prevalence, Dermatitis, Atopic drug therapy, Eczema
Abstract

Introduction: The epidemiology of atopic dermatitis (AD) is largely different in pre-school and schoolchildren. We summarized the available epidemiological data on schoolchildren (6-11 years) and adolescents (12-17 years) in Italy and reviewed information on systemic treatments for moderate-to-severe AD in adolescents., Evidence Acquisition: In January 2019, we searched for data on prevalence and/or incidence of AD and on the efficacy, effectiveness and safety of systemic AD therapies. Papers were evaluated and selected, and relevant information was extracted. Twenty papers from 17 studies reported original epidemiological information on AD in Italy., Evidence Synthesis: Most studies were conducted before 2005. Though variations emerged between studies, the lifetime prevalence of AD was estimated between 15-17% in schoolchildren and between 8-13% in adolescents. The (12-months) period prevalence of AD was estimated between 8-10% in children and between 8-11% in adolescents. Up-to-date information on the prevalence of severe AD is not available. Cyclosporine A may be used in pediatric age patients (children and adolescents) with persistent or severe AD refractory to topical treatments, but its use has several limitations, and is not recommended in patients younger than 16 years. The treatment paradigm of AD is still far from being satisfactory., Conclusions: We provided a quantitative synthesis of AD epidemiology in Italian schoolchildren and adolescents. Recent data are needed, as most information dates back to the 1990s or early 2000s, and data on the incidence of AD, the proportion of severe cases, and treatment of severe cases in the real-world setting are scanty.

Published
2021
Full Text
View/download PDF

23. Diagnosis and management of moderate to severe atopic dermatitis in adolescents. A Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists and Public Health (ADOI), the Italian Association of Hospital and Territorial Allergists and Immunologists (AAIITO), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), the Italian Society of Pediatric Allergy and Immunology (SIAIP), the Italian Society of Allergological, Occupational and Environmental Dermatology (SIDAPA), and the Italian Society of Pediatric Dermatology (SIDerP).

Author

Calzavara-Pinton P, Belloni Fortina A, Bonamonte D, Marseglia GL, Miraglia Del Giudice M, Musarra A, Nettis E, Neri I, Patruno C, Stingeni L, and Peris K

Subjects
Adolescent, Adult, Allergists, Child, Consensus, Dermatologists, Hospitals, Humans, Italy, Public Health, Quality of Life, Asthma, Dermatitis, Atopic diagnosis, Dermatology, Venereology
Abstract

Atopic dermatitis (AD) is a chronic inflammatory disease with increasing global incidence, which has a multifactorial pathogenesis and a variable expressivity. Clinical features of AD are different in adults compared to children, but it is well recognized the substantial impact of the disease on patients' quality of life at any age. Indeed, little is known about AD in adolescence, a period of life generally associated with high psychological burden and vulnerability to depression. Guidelines for the management of AD are available for both children and adults but specific guidelines for the diagnosis and treatment of AD in adolescents are lacking. Seven Italian scientific societies of dermatologists, allergists, and pediatric allergists joined in a specific meeting to provide practical guidance for the diagnosis and management of moderate-to-severe adolescent AD suitable for the Italian clinical practice. Through a modified Delphi procedure, consensus was reached by 59 Italian experts in the management of AD on 20 statements covering five areas of interest about adolescent AD, including disease complexity, burden and social impact, diagnosis and definition of severity, current treatments, and new biologic therapies. This paper reports recommendations for the diagnosis and management of AD specifically in adolescents, pointing out some peculiar clinical features and focusing on the choice of medications. Dupilumab, the first biologic approved for the treatment of adolescents with AD, represents a useful treatment option due to its efficacy and reassuring safety profile.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results